Ray, W. A., et al. (2024). Incidence of Neuroleptic Malignant Syndrome During Antipsychotic Treatment in Children and Youth: A National Cohort Study. Journal of Child and Adolescent ...

In various reports, neuroleptic malignant syndrome develops in an estimated 0.02 to 3% of patients exposed to an implicated drug, depending on the population studied, the agent, the duration of ...

Lane’s death was deemed natural by the county coroner’s office and is officially listed as Neuroleptic Malignant Syndrome. NMS is a known, but rare, side effect of anti-psychotic medications.

Neuroleptic malignant syndrome is a neurological condition associated with the use of antipsychotic medications. Learn about its symptoms, causes, and more.

A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of ...

A new study in the Journal of Child and Adolescent Psychopharmacology estimates the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic treatment ...

A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of ...